EWZ Is Up About 20% This Year. Here Is What Drives the Return.
Brazil’s rally is real, but for U.S. investors the currency does as much work as the index.
Brazil’s rally is real, but for U.S. investors the currency does as much work as the index.
Five straight quarters of double-digit comps, 52 new stores, and a $600 million buyback make Five Below the clearest buy…
The Angelman trial missed both endpoints, cost cuts loom, and an FDA decision is 16 days away.
With hike odds near 60% and the 10-year around 4.75%, JPMorgan went cautious Monday. Goldman says that caution is misplaced.
Ciena beats estimates and gets punished. Four days before it reports again, the stock sits 22% below its post-earnings high.
The breadth scorecard from Thursday's historic move shows where the chip trade is concentrated and where it isn't.
Record Q2 sales, a Trane partnership, and a 307 GW data center backlog that compounds quietly.
A $10 billion research lab, a 50% supply shortfall, and a forward P/E of 6.76 are telling three different parts…
BofA's Hartnett says the debt-service spiral is the real threat, not the round number.
A 109% revenue surge and Q1 guidance 8% above consensus are the headline. The 30%+ supply gap underneath is the…